Malin Corporation plc
Notice of Full Year 2019 Results and Publication of 2019 Annual Report
Dublin-Ireland, 5 March 2020: Malin Corporation plc. (Euronext Growth Dublin:MLC) ("Malin"), a company investing in highly innovative life sciences companies, today announces that it intends to report its results and publish its annual report for the year ended 31 December 2019 at 7:00am GMT on Wednesday, 25 March 2020.
Darragh Lyons, Chief Executive Officer, will host a conference call for analysts and investors at 11:00am GMT on the day of publication. This call can be accessed as follows:
From Ireland dial: +353 (0) 1 431 9615
From the UK dial: +44 (0) 844 571 8892
From the USA dial: +(1) 6315 107 495
From other locations dial: +44 (0) 2071 928 000
Participant PIN code: 8174626
ENDS
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com
For further information please contact:
Malin
Jessica Bergin, Investor Relations & External Reporting
Tel: +353 (0)1 901 5700
investorrelations@malinplc.com
Davy Corporate Finance (Euronext Growth Adviser & Joint Broker)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
Liberum (Joint Broker)
Bidhi Bhoma / Euan Brown
Tel: +44 (0) 20 3100 2000
Consilium Strategic Communications
Mary-Jane Elliott / Chris Welsh
Tel: +44 (0)20 3709 5700
malin@consilium-comms.com
Powerscourt (Irish media enquiries)
Eavan Gannon
Tel: +353 87 236 5973
malin@powerscourt-group.com